VYGR

Conviction 20HealthcareScan · Fri, Jun 26, 2026

VYGR$3.58+0.85%

ResistanceSupportVol 14

Vol MA14 555K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Voyager Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.voyagertherapeutics.com ↗

Price3.58

Change+0.85%

Gap-0.56%

Rel volume2.45×

Avg volume548.63K

Avg $ vol1.96M

SMA 203.58

SMA 503.77

SMA 2004.08

Price vs 50-5.15%

Price vs 200-12.25%

MA stackbearish

50/200 cross—

Supertrenddown · 4.05

RSI (14)47

MACD hist0.02

MACD crossbull · 7d

Stoch %K / %D57 / 61

ADX (14)11

+DI / −DI17 / 21

RSI divergence—

MACD divergenceBullish

ATR %+5.26%

ADR %5.24%

52w high5.33

52w low2.96

From 52w high-32.83%

Above 52w low+20.95%

New 52w highNo

SqueezeOff

Bollinger width16.17%

%B0.50

Donchian pos47.76%

Donchian high3.93

Donchian low3.26

AVWAP (52w high)4.10

vs AVWAP high-12.64%

AVWAP (52w low)3.98

vs AVWAP low-10.15%

OBV trendFlat

Chaikin MF (20)-0.21

Today vs 20d2.45×

Avg vol (14d)555K

Avg vol (20d)548.63K

Avg $ vol (20d)1.96M

Market cap—

RS 3m (vs SPY)-23.71%

RS 6m (vs SPY)-22.90%

RS line new highNo

Trend template0/8

Technical rank22.1

1 week-3.76%

1 month-8.91%

3 months-13.32%

6 months-10.28%

1 year+21.77%

YTD-11.17%

P/E-1.80

P/B1.24

P/S5.33

P/FCF-1.59

EPS-2.04

Div yield—

ROE-68.94%

ROA-54.59%

Debt/Eq—

Current8.42

EV/EBITDA—

Gross margin—

Net margin-296.53%

Rev growth-49.53%

EPS growth-84.18%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value171.79M

Revenue2.59M

Net income-27.94M

Gross profit—

Free cash flow-135.06M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out60.42M

Employees141

ListedWed, Nov 11, 2015

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank22.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.37

Support3.27

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VYGR

All disclosures →

No recent disclosed trades by Congress in VYGR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VYGR

No recent insider (Form 4) filings in VYGR. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in VYGR · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.